Abstract
Background
Breastfeeding is associated with improved cardiometabolic profiles decades after pregnancy. Whether this association exists for women who experience hypertensive disorders of pregnancy (HDP) is unknown. The authors examined whether breastfeeding duration or exclusivity are associated with long‐term cardiometabolic health, and whether this relationship differs by HDP status.
Methods and Results
Participants (N=3598) were from the UK ALSPAC (Avon Longitudinal Study of Parents and Children) cohort. HDP status was assessed by medical record review. Breastfeeding behaviors were assessed by contemporaneous questionnaires. Breastfeeding duration was categorized as never,
Conclusions
Breastfeeding may be a mechanism to reduce the cardiovascular disease sequela associated with HDP; however, there is a need to establish whether associations reflect a causal effect.
Breastfeeding is associated with improved cardiometabolic profiles decades after pregnancy. Whether this association exists for women who experience hypertensive disorders of pregnancy (HDP) is unknown. The authors examined whether breastfeeding duration or exclusivity are associated with long‐term cardiometabolic health, and whether this relationship differs by HDP status.
Methods and Results
Participants (N=3598) were from the UK ALSPAC (Avon Longitudinal Study of Parents and Children) cohort. HDP status was assessed by medical record review. Breastfeeding behaviors were assessed by contemporaneous questionnaires. Breastfeeding duration was categorized as never,
Conclusions
Breastfeeding may be a mechanism to reduce the cardiovascular disease sequela associated with HDP; however, there is a need to establish whether associations reflect a causal effect.
| Original language | English |
|---|---|
| Article number | e026696 |
| Journal | Journal of the American Heart Association |
| Volume | 12 |
| Issue number | 5 |
| Early online date | 27 Feb 2023 |
| DOIs | |
| Publication status | E-pub ahead of print - 27 Feb 2023 |
Bibliographical note
Funding Information:The UK Medical Research Council, Wellcome (grant reference: 102215/2/13/2) and the University of Bristol provide core support for ALSPAC. A comprehensive list of grant funding is available on the ALSPAC website (http://www.brist ol.ac.uk/alspac/external/documents/grant-acknowledgements.pdf). This work was partly supported by the Research Council of Norway through its Centres of Excellence funding scheme, project number 262700. M.C.M. has received funding from the European Research Council under the European Union’s Horizon 2020 research and innovation programme (grant agreement number 947684). This work was also supported by NIH/NINR T32NR009759.
Publisher Copyright:
© 2023 The Authors. Published on behalf of the American Heart Association, Inc., by Wiley.